Back to CADL

Candel Therapeutics, Inc. 10-Q

Accession 0000950170-22-024197

Filing information

CIK
0001841387
Report date
2022-09-30
Filing date
2022-11-10
Form
10-Q
Primary document
cadl-20220930.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.